Literature DB >> 14561495

Identification of novel GDAP1 mutations causing autosomal recessive Charcot-Marie-Tooth disease.

Nadia Ammar1, Eva Nelis, Luciano Merlini, Nina Barisić, Rim Amouri, Chantal Ceuterick, Jean Jacques Martin, Vincent Timmerman, Fayçal Hentati, Peter De Jonghe.   

Abstract

Mutations in the ganglioside-induced differentiation-associated protein 1 gene cause either autosomal recessive demyelinating Charcot-Marie-Tooth disease type 4A or autosomal recessive axonal Charcot-Marie-Tooth disease with vocal cord paresis. We sequenced the ganglioside-induced differentiation-associated protein 1 gene in 138 patients from 119 unrelated families diagnosed with either demyelinating or axonal autosomal recessive Charcot-Marie-Tooth disease. We detected six distinct mutant alleles in four families, four of which are novel. Electrophysiological studies show severely slowed motor nerve conduction velocities with severely reduced compound muscle action potentials. However, one patient had a normal conduction velocity in the ulnar nerve. Based on the electrophysiological tests, patients with ganglioside-induced differentiation-associated protein 1 mutations will therefore be classified as either axonal or demyelinating Charcot-Marie-Tooth disease. The neuropathological aspect shows a divergent pattern; nerve biopsies taken from two siblings at the same age and sharing the same ganglioside-induced differentiation-associated protein 1 gene mutation showed a dissimilar severity stage.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14561495     DOI: 10.1016/s0960-8966(03)00093-2

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  14 in total

1.  Charcot-Marie-Tooth disease: genetic and clinical spectrum in a Spanish clinical series.

Authors:  Rafael Sivera; Teresa Sevilla; Juan Jesús Vílchez; Dolores Martínez-Rubio; María José Chumillas; Juan Francisco Vázquez; Nuria Muelas; Luis Bataller; José María Millán; Fancesc Palau; Carmen Espinós
Journal:  Neurology       Date:  2013-09-27       Impact factor: 9.910

2.  A frameshift mutation in LRSAM1 is responsible for a dominant hereditary polyneuropathy.

Authors:  Marian A J Weterman; Vincenzo Sorrentino; Paul R Kasher; Marja E Jakobs; Baziel G M van Engelen; Kees Fluiter; Marit B de Wissel; Aleksander Sizarov; Gudrun Nürnberg; Peter Nürnberg; Noam Zelcer; H Jurgen Schelhaas; Frank Baas
Journal:  Hum Mol Genet       Date:  2011-10-19       Impact factor: 6.150

3.  Unraveling the genetic landscape of autosomal recessive Charcot-Marie-Tooth neuropathies using a homozygosity mapping approach.

Authors:  Magdalena Zimoń; Esra Battaloğlu; Yesim Parman; Sevim Erdem; Jonathan Baets; Els De Vriendt; Derek Atkinson; Leonardo Almeida-Souza; Tine Deconinck; Burcak Ozes; Dirk Goossens; Sebahattin Cirak; Philip Van Damme; Mohammad Shboul; Thomas Voit; Lionel Van Maldergem; Bernard Dan; Mohammed S El-Khateeb; Velina Guergueltcheva; Eduardo Lopez-Laso; Nathalie Goemans; Amira Masri; Stephan Züchner; Vincent Timmerman; Haluk Topaloğlu; Peter De Jonghe; Albena Jordanova
Journal:  Neurogenetics       Date:  2014-09-18       Impact factor: 2.660

Review 4.  Molecular genetics of autosomal-recessive axonal Charcot-Marie-Tooth neuropathies.

Authors:  Rafaëlle Bernard; Annachiara De Sandre-Giovannoli; Valérie Delague; Nicolas Lévy
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

5.  L239F founder mutation in GDAP1 is associated with a mild Charcot-Marie-Tooth type 4C4 (CMT4C4) phenotype.

Authors:  Dagmara Kabzińska; Halina Strugalska-Cynowska; Anna Kostera-Pruszczyk; Barbara Ryniewicz; Renata Posmyk; Alina Midro; Pavel Seeman; Lucia Báranková; Magdalena Zimoń; Jonathan Baets; Vincent Timmerman; Velina Guergueltcheva; Ivailo Tournev; Stayko Sarafov; Peter De Jonghe; Albena Jordanova; Irena Hausmanowa-Petrusewicz; Andrzej Kochański
Journal:  Neurogenetics       Date:  2010-03-16       Impact factor: 2.660

6.  Genotype-phenotype correlation and frequency of distribution in a cohort of Chinese Charcot-Marie-Tooth patients associated with GDAP1 mutations.

Authors:  Pukar Singh Pakhrin; Yongzhi Xie; Zhengmao Hu; Xiaobo Li; Lei Liu; Shunxiang Huang; Binghao Wang; Zihan Yang; Jiejun Zhang; Xin Liu; Kun Xia; Beisha Tang; Ruxu Zhang
Journal:  J Neurol       Date:  2018-01-25       Impact factor: 4.849

7.  Two novel mutations in the GDAP1 and PRX genes in early onset Charcot-Marie-Tooth syndrome.

Authors:  M Auer-Grumbach; C Fischer; L Papić; E John; B Plecko; R E Bittner; G Bernert; T R Pieber; G Miltenberger; R Schwarz; C Windpassinger; F Grill; V Timmerman; M R Speicher; A R Janecke
Journal:  Neuropediatrics       Date:  2008-02       Impact factor: 1.947

8.  Dominant GDAP1 mutations cause predominantly mild CMT phenotypes.

Authors:  M Zimoń; J Baets; G M Fabrizi; E Jaakkola; D Kabzińska; J Pilch; A B Schindler; D R Cornblath; K H Fischbeck; M Auer-Grumbach; C Guelly; N Huber; E De Vriendt; V Timmerman; U Suter; I Hausmanowa-Petrusewicz; A Niemann; A Kochański; P De Jonghe; A Jordanova
Journal:  Neurology       Date:  2011-07-13       Impact factor: 9.910

9.  Ganglioside-induced differentiation associated protein 1 is a regulator of the mitochondrial network: new implications for Charcot-Marie-Tooth disease.

Authors:  Axel Niemann; Marcel Ruegg; Veronica La Padula; Angelo Schenone; Ueli Suter
Journal:  J Cell Biol       Date:  2005-09-19       Impact factor: 10.539

10.  Cell expression of GDAP1 in the nervous system and pathogenesis of Charcot-Marie-Tooth type 4A disease.

Authors:  Laia Pedrola; Antonio Espert; Teresa Valdés-Sánchez; Maribel Sánchez-Piris; Erich E Sirkowski; Steven S Scherer; Isabel Fariñas; Francesc Palau
Journal:  J Cell Mol Med       Date:  2007-11-16       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.